Repurposed Drug Flops in MS Trial, but Study Design Is Big Winner

(MedPage Today) -- Repurposed domperidone was futile in a phase II secondary progressive multiple sclerosis (MS) trial, but the study may point to a novel way of evaluating generic drugs for MS treatment.
A Simon two-stage futility trial of domperidone...